UTI Healthcare Fund Direct-Growth
NAV
₹331.0900
as on 17 Oct 2025, 11:13 PM
₹0.2024(0.06%)
Last Change
Schemes Managed By
Scheme Information
UTI Healthcare Fund Direct-Growth
as of 30 Sep 2025, 05:30 AM
₹1,096.95 Cr
1.30%
1.01%
Open-End
Growth
Exit load of 1% if redeemed within 30 days.
BSE Healthcare Total Return Index
View
Sectors Holding in this Mutual Fund
Healthcare
98.98%
₹1,085.71 Cr
Others
1.02%
₹11.19 Cr
Healthcare
98.98%
₹1,085.71 Cr
Others
1.02%
₹11.19 Cr
Sun Pharmaceutical Industries Ltd.
10.44%
₹114.52 Cr
Cipla Ltd.
5.52%
₹60.55 Cr
Dr. Reddy's Laboratories Ltd.
4.66%
₹51.12 Cr
Procter & Gamble Health Ltd.
4.34%
₹47.61 Cr
Ajanta Pharma Ltd.
4.09%
₹44.87 Cr
Others
70.95%
₹778.29 Cr
Sun Pharmaceutical Industries Ltd.
10.44%
₹114.52 Cr
Cipla Ltd.
5.52%
₹60.55 Cr
Dr. Reddy's Laboratories Ltd.
4.66%
₹51.12 Cr
Procter & Gamble Health Ltd.
4.34%
₹47.61 Cr
Ajanta Pharma Ltd.
4.09%
₹44.87 Cr
Others
70.95%
₹778.29 Cr
Funds in this Category
This fund's returns: 26.16%
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
Min. Investment
₹100
29.12
Category Returns
19.68%
29.12%
3Y Returns
29.12 %
SBI Healthcare Opportunities Fund Direct Plan-Growth
Min. Investment
₹500
27.39
Category Returns
19.68%
29.12%
3Y Returns
27.39 %
DSP Healthcare Fund Direct - Growth
Min. Investment
₹100
24.80
Category Returns
19.68%
29.12%
3Y Returns
24.80 %
About UTI Healthcare Fund Direct-Growth
UTI Healthcare Fund Direct-Growth scheme return performance in last 1 year is 2.97%, in last 3 years is 100.92% and 593.82% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Details
| AUM: | ₹1,096.95 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
UTI Mutual Fund
Address
Investment Performance
₹ 1,00,000
would have given a return of
₹1,10,871
₹1,21,647
₹1,95,025
₹2,00,917
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
Profit (absolute return)
₹1,00,918
100.92%
Investment Returns
Scheme Riskometer
Investors understand that their principal will be at very high risk
